Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Chau

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
BMC Cancer|October 7, 2011
Early mortality and overall survival in oncology phase I trial participants: can we improve patient selection?Nicole G Chau, Ana Florescu, Kelvin K Chan, et al.
Angewandte Chemie (International Ed. in English)|April 1, 2026
Band Gap Tuneability in Antiperovskite-Based Nitrides AE<sub>3</sub>PnN and Imides AE<sub>5</sub>Pn<sub>2</sub>(NH)<sub>2</sub> (AE = Ca, Sr; Pn = As, Sb, Bi)Thanh G Chau, Florian Wolf, Dan Han, et al.
Advances in Radiation Oncology|April 14, 2020
Microcystic Adnexal Carcinoma of the Face Treated With Definitive Chemoradiation: A Case Report and Review of the LiteratureDaniel W Kim, Grace Lee, Miranda B Lam, et al.
Oral Oncology|April 14, 2020
Long-term outcomes and clinicogenomic correlates in recurrent, metastatic adenoid cystic carcinomaGlenn J Hanna, Ji Eun Bae, Jochen H Lorch, et al.
Oral Oncology|September 18, 2018
Radiologic predictors of immune checkpoint inhibitor response in advanced head and neck squamous cell carcinomaVishwajith Sridharan, Rifaquat M Rahman, Raymond Y Huang, et al.
Laryngoscope Investigative Otolaryngology|December 28, 2020
Circulating tumor cell analysis in locally advanced and metastatic squamous cell carcinoma of the head and neckEthan J Harris, Julian Huang, Erin Carroll, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 17, 2018
Safety and clinical activity of atezolizumab in head and neck cancer: results from a phase I trialA D Colevas, R Bahleda, F Braiteh, et al.
Frontiers in Oncology|November 19, 2024
Multidisciplinary Canadian consensus on the multimodal management of high-risk and radioactive iodine-refractory thyroid carcinomaShereen Ezzat, Jesse D Pasternak, Murali Rajaraman, et al.
European Journal of Cancer (Oxford, England : 1990)|April 8, 2019
Chromosome 3q arm gain linked to immunotherapy response in advanced cutaneous squamous cell carcinomaAlec J Kacew, Ethan J Harris, Jochen H Lorch, et al.
Head & Neck Oncology|March 1, 2011
The association between EGFR variant III, HPV, p16, c-MET, EGFR gene copy number and response to EGFR inhibitors in patients with recurrent or metastatic squamous cell carcinoma of the head and neckNicole G Chau, Bayardo Perez-Ordonez, Katherine Zhang, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
BMC Cancer|October 7, 2011
Early mortality and overall survival in oncology phase I trial participants: can we improve patient selection?Nicole G Chau, Ana Florescu, Kelvin K Chan, et al.
Angewandte Chemie (International Ed. in English)|April 1, 2026
Band Gap Tuneability in Antiperovskite-Based Nitrides AE<sub>3</sub>PnN and Imides AE<sub>5</sub>Pn<sub>2</sub>(NH)<sub>2</sub> (AE = Ca, Sr; Pn = As, Sb, Bi)Thanh G Chau, Florian Wolf, Dan Han, et al.
Advances in Radiation Oncology|April 14, 2020
Microcystic Adnexal Carcinoma of the Face Treated With Definitive Chemoradiation: A Case Report and Review of the LiteratureDaniel W Kim, Grace Lee, Miranda B Lam, et al.
Oral Oncology|April 14, 2020
Long-term outcomes and clinicogenomic correlates in recurrent, metastatic adenoid cystic carcinomaGlenn J Hanna, Ji Eun Bae, Jochen H Lorch, et al.
Oral Oncology|September 18, 2018
Radiologic predictors of immune checkpoint inhibitor response in advanced head and neck squamous cell carcinomaVishwajith Sridharan, Rifaquat M Rahman, Raymond Y Huang, et al.
Laryngoscope Investigative Otolaryngology|December 28, 2020
Circulating tumor cell analysis in locally advanced and metastatic squamous cell carcinoma of the head and neckEthan J Harris, Julian Huang, Erin Carroll, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 17, 2018
Safety and clinical activity of atezolizumab in head and neck cancer: results from a phase I trialA D Colevas, R Bahleda, F Braiteh, et al.
Frontiers in Oncology|November 19, 2024
Multidisciplinary Canadian consensus on the multimodal management of high-risk and radioactive iodine-refractory thyroid carcinomaShereen Ezzat, Jesse D Pasternak, Murali Rajaraman, et al.
European Journal of Cancer (Oxford, England : 1990)|April 8, 2019
Chromosome 3q arm gain linked to immunotherapy response in advanced cutaneous squamous cell carcinomaAlec J Kacew, Ethan J Harris, Jochen H Lorch, et al.
Head & Neck Oncology|March 1, 2011
The association between EGFR variant III, HPV, p16, c-MET, EGFR gene copy number and response to EGFR inhibitors in patients with recurrent or metastatic squamous cell carcinoma of the head and neckNicole G Chau, Bayardo Perez-Ordonez, Katherine Zhang, et al.
Pageof 7